Urbanization and foreign travel have caused a 30-fold increase in dengue epidemic risk in India and Southeast Asia over the past 20 years, according to the WHO. The virus causes 16% of travel-related febrile infections, underlining the need for vector management.
According to the World Health Organisation (WHO) India and other Southeast Asian countries have seen a 30-fold increase in dengue epidemic risk over the past two decades.
Platelet-related infections and other overlooked variables contributed. Dengue virus has roughly four serotypes since its 1943 discovery.
According to the WHO’s “South-east Asia dialogue,” urbanization and international travel help spread dengue, which accounts for 16% of travel-related febrile diseases.
“The epidemic risk has surged from 8 to 30-fold in recent decades, with dengue now contributing to 16% of travel-related febrile illnesses,” the conversation stated.
Document emphasizes virus delivery to female Aedes mosquito eggs, resulting in virus-infected insects. Vector management tactics must include adult mosquitoes, larvae, and eggs. The research also highlights neglected dengue control issues such blood transfusions, sexually transmitted infections, needle stick injuries, and mother-to-child transmission. The WHO research warns that blood donation during dengue epidemics may involve asymptomatic carriers and urges screening for dengue.
According to the document, every second Indian is at danger of dengue due to travel and urbanization. Dr. Kiran Madhala, a medical expert, stressed the importance of vaccination. Thus, vaccination is the only solution.”
Conclusion
The WHO has reported a 30-fold increase in dengue epidemic risk in India and Southeast Asia over the previous two decades. The virus now causes 16% of travel-related fevers. It spreads due to urbanization, international travel, and overlooked variables such platelet-related diseases. According to the WHO, vector control must include adult mosquitoes, larvae, and eggs. Dengue screening of donated blood is also stressed.
